Obviously the COV-19 virus has been the catalyst for the MSB SP growth.
Looking at statistics from : https://www.worldometers.info/coronavirus/, the number of deaths worldwide including USA has dropped significantly (over 50%) over the last few days, and if this decline continues at this rate then by the time we have completed our trials, there may be little need for our product with regard to COV-19. Thoughts anyone
Howie
Cell Therapy News/Articles, page-2221
-
- There are more pages in this discussion • 15,804 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.0¢ |
Change
-0.005(0.51%) |
Mkt cap ! $1.107B | |||
| Open | High | Low | Value | Volume |
| 98.5¢ | 98.5¢ | 96.0¢ | $2.168M | 2.226M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 16000 | 96.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.0¢ | 86854 | 7 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |